Safety and efficacy of solvent/detergent-treated antihaemophilic factor with an added 80 °C terminal dry heat treatment in patients with haemophilia A
- 1 May 2000
- journal article
- clinical trial
- Published by Wiley in Haemophilia
- Vol. 6 (3), 140-149
- https://doi.org/10.1046/j.1365-2516.2000.00407.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma poolJournal of Medical Virology, 1999
- Viral safety of plasma‐derived and recombinant products used in the management of haemophilia A and BHaemophilia, 1995
- Effect of Terminal (Dry) Heat Treatment on Non‐Enveloped Viruses in Coagulation Factor ConcentratesVox Sanguinis, 1994
- Prospective study of the evaluation of hepatitis C virus infectivity in a high‐purity, solvent/detergent‐treated factor VIII concentrate: parallel evaluation of other markers for lipid‐enveloped and non‐lipid‐ enveloped viruses.Transfusion, 1993
- Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion Practices CommitteeTransfusion, 1993
- Serological evidence that dry heating of clotting factor concentrates prevents transmission of non-A, non-B hepatitisJournal of Medical Virology, 1990
- Revision of the Protocol Recommended for Studies of Safety from Hepatitis of Clotting Factor ConcentratesThrombosis and Haemostasis, 1989
- A Prospective Study of Human Immunodeficiency Virus Type 1 Infection and the Development of AIDS in Subjects with HemophiliaNew England Journal of Medicine, 1989
- Severe Heat Treatment of Lyophilised Coagulation FactorsPublished by S. Karger AG ,1988
- VIRUS SAFETY OF SOLVENT/DETERGENT-TREATED ANTIHAEMOPHILIC FACTOR CONCENTRATEThe Lancet, 1988